Update on lipid management: commonly asked questions

View/ Open
Author(s)
Hamilton-Craig, I
Griffith University Author(s)
Year published
2012
Metadata
Show full item recordAbstract
LDL-cholesterol (LDL-C) target levels in patients with cardiovascular disease (CVD) are getting lower. New statin combinations will be more cost effective than present combinations and will help to achieve LDL-C targets. These and other drugs in development promise a new era in CVD prevention.LDL-cholesterol (LDL-C) target levels in patients with cardiovascular disease (CVD) are getting lower. New statin combinations will be more cost effective than present combinations and will help to achieve LDL-C targets. These and other drugs in development promise a new era in CVD prevention.
View less >
View less >
Journal Title
Medicine Today
Volume
13
Issue
1
Publisher URI
Copyright Statement
© 2012 Medicine Today Pty. Ltd.. Reproduced in accordance with the copyright policy of the publisher. Use hypertext link for access to the publisher's website.
Subject
Biomedical and clinical sciences